AA
ARNA

ALPS Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

ALPS Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-74,855
Closed -$4.46M – 1003
2021
Q3 		$4.46M Sell
74,855
-4,786
-6% -$283K 0.04% 181
2021
Q2 		$5.43M Sell
79,641
-25,588
-24% -$1.67M 0.05% 170
2021
Q1 		$7.3M Buy
105,229
+1,032
+1% +$79.4K 0.07% 155
2020
Q4 		$8.01M Buy
104,197
+30,683
+42% +$2.3M 0.09% 149
2020
Q3 		$5.5M Sell
73,514
-2,654
-3% -$177K 0.08% 153
2020
Q2 		$4.79M Sell
76,168
-14,926
-16% -$821K 0.06% 155
2020
Q1 		$3.83M Sell
91,094
-16,660
-15% -$764K 0.06% 161
2019
Q4 		$4.89M Buy
107,754
+1,335
+1% +$63.1K 0.04% 159
2019
Q3 		$4.87M Buy
106,419
+3,037
+3% +$171K 0.04% 143
2019
Q2 		$6.06M Sell
103,382
-15,952
-13% -$824K 0.04% 147
2019
Q1 		$5.35M Buy
119,334
+5,155
+5% +$236K 0.04% 157
2018
Q4 		$4.45M Buy
114,179
+26,853
+31% +$1.05M 0.03% 160
2018
Q3 		$4.02M Buy
87,326
+16,332
+23% +$662K 0.03% 182
2018
Q2 		$3.1M Buy
70,994
+18,392
+35% +$790K 0.02% 199
2018
Q1 		$2.08M Buy
52,602
+9,142
+21% +$356K 0.02% 211
2017
Q4 		$1.48M Buy
+43,460
New +$1.24M 0.01% 215
2015
Q4 		– Sell
-37,885
Closed -$7.24K – 707
2015
Q3 		$7.24K Buy
37,885
+13,863
+58% +$471K 0.01% 227
2015
Q2 		$1.11M Buy
24,022
+11,874
+98% +$515K 0.01% 207
2015
Q1 		$531K Buy
+12,148
New +$565K ﹤0.01% 384

Other funds holding ARNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ALPS Advisors's ARNA Position: Q4 2021 in Review

ALPS Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2021, closing a stake of 74,855 shares — an estimated $4.46M sold.

ALPS Advisors first reported a position in ARNA in Q1 2015 and held it in 19 quarters. The position peaked at $8.01M in Q4 2020. 316 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

  • ALPS Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
  • ALPS Advisors sold 74,855 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $4.46M.
  • ALPS Advisors first reported a position in Arena Pharmaceuticals Inc in Q1 2015 and held it in 19 quarters.
  • ALPS Advisors's Arena Pharmaceuticals Inc position peaked at $8.01M in Q4 2020.
  • 316 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on ALPS Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.